日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Human Umbilical Cord Plasma Metabolomics Uncover Potential Metabolites for Combating Aging

人类脐带血浆代谢组学揭示对抗衰老的潜在代谢物

Liu, JiaYu; Jiang, Shuai; Shen, YanYan; Wang, RuiBo; Jin, Zhi; Cao, YanQing; Li, JinLiang; Liu, YanHong; Qi, Qi; Guo, Yue; Wang, YunYing; Xie, BoYang; Li, JunCheng; Cao, AiPing; Wang, Yao; Yan, ChunYan; Han, QiuYing; Zhu, YingJie; Peng, Jing; Dong, FangTing; Pan, Xin; He, XinHua; Zhou, Tao; Li, AiLing; He, Kun; Wang, Na; Zhang, WeiNa; Xia, Qing

Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer

舒格利单抗联合化疗一线治疗晚期胃癌或胃食管交界处癌的成本效益分析

Yan, Chunyan; He, Jing; Lv, Guoguang; Gao, Yuan; Li, Jiayan; Diao, Ruigang

Short-Term Change in IgG Antibody Elicited by Omicron BA.5 Infection and Inhaled Ad5-nCoV Vaccine Among Healthcare Workers

医护人员感染 Omicron BA.5 病毒和吸入 Ad5-nCoV 疫苗后 IgG 抗体的短期变化

Luo, Zhaohui; Zeng, Ting; Zhao, Shi; Liang, Jing; Sun, Shengzhi; Ni, Yongkang; Yan, Chunyan; Yin, Liang; Wang, Lan; Wang, Kai; Guo, Zihao

Cost-effectiveness of sugemalimab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced oesophageal squamous cell carcinoma in China

在中国,舒格马利单抗联合化疗与安慰剂联合化疗作为晚期食管鳞状细胞癌一线治疗方案的成本效益分析

Yan, Chunyan; Li, Zhengxiong; Li, Jiayan; Huang, Ruiqin; Li, Shuqing; Diao, Ruigang

Cost-effectiveness of benmelstobart and anlotinib plus chemotherapy as first-line therapy for extensive-stage small cell lung cancer in China

在中国,苯妥英钠和安罗替尼联合化疗作为广泛期小细胞肺癌一线治疗方案的成本效益分析

Yan, Chunyan; Li, Zhengxiong; Li, Jiayan; Zhao, Quan; Cao, Wenxiu; Li, Shuqing; Diao, Ruigang

Effect of Quenching Temperature on Microstructure and Hydrogen-Induced Cracking Susceptibility in S355 Steel

淬火温度对S355钢显微组织和氢致裂纹敏感性的影响

Yan, Chunyan; Zhang, Shenglin; Zhou, Lingchuan; Tian, Zhanpeng; Shen, Mengdie; Liu, Xinyi

Utility of a Caprini-combined prediction model in patients with gynecological venous thromboembolism in China

Caprini联合预测模型在中国妇科静脉血栓栓塞患者中的应用价值

Ma, Lijuan; Mao, Lei; Jia, Peipei; Wang, Lin; Han, Lili; Zhang, Xiumin; Hou, Ming; Ren, Haiyan; Yan, Chunyan; Tang, Qingfeng; Han, Tao; Yakufu, Kereman

Comparison of different hydromorphone bolus doses in patient-controlled intravenous analgesia for post-laparoscopic surgery: a randomized controlled trial

比较不同剂量氢吗啡酮单次静脉推注用于腹腔镜术后患者自控静脉镇痛的效果:一项随机对照试验

Li, Xinlong; Liu, Minjun; Chen, Gang; Yan, Chunyan

Cost-effectiveness analysis of penpulimab combined with paclitaxel and carboplatin as a first-line treatment for metastatic squamous non-small cell lung cancer in China

在中国,以青霉素单抗联合紫杉醇和卡铂作为转移性鳞状非小细胞肺癌一线治疗方案的成本效益分析

Wang, Liangxiao; Lv, Na; Gao, Yuan; Yan, Chunyan; Huo, Xuechen; Diao, Ruigang

PD-1 inhibitors in advanced esophageal squamous cell carcinoma: a survival analysis of reconstructed patient-level data

PD-1抑制剂在晚期食管鳞状细胞癌中的应用:基于重建患者水平数据的生存分析

Yan, Chunyan; Cao, Wenxiu; Li, Jianghua; Zhang, Lei; Diao, Ruigang